BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22003930)

  • 1. In vivo confocal microscopy of Meissner corpuscles as a novel sensory measure in CMT1A.
    Almodovar JL; Ferguson M; McDermott MP; Lewis RA; Shy ME; Herrmann DN
    J Peripher Nerv Syst; 2011 Sep; 16(3):169-74. PubMed ID: 22003930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo confocal microscopy of Meissner corpuscles as a measure of sensory neuropathy.
    Herrmann DN; Boger JN; Jansen C; Alessi-Fox C
    Neurology; 2007 Dec; 69(23):2121-7. PubMed ID: 17898322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathy progression in Charcot-Marie-Tooth disease type 1A.
    Shy ME; Chen L; Swan ER; Taube R; Krajewski KM; Herrmann D; Lewis RA; McDermott MP
    Neurology; 2008 Jan; 70(5):378-83. PubMed ID: 18227419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus exacerbates motor and sensory impairment in CMT1A.
    Sheth S; Francies K; Siskind CE; Feely SM; Lewis RA; Shy ME
    J Peripher Nerv Syst; 2008 Dec; 13(4):299-304. PubMed ID: 19192070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Reflectance Microscopy of Meissner Corpuscles and Bedside Measures of Large Fiber Sensory Function: A Normative Data Cohort.
    Creigh PD; Du K; Wood EP; Mountain J; Sowden J; Charles J; Behrens-Spraggins S; Herrmann DN
    Neurology; 2022 Feb; 98(7):e750-e758. PubMed ID: 34880095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small nerve fiber involvement in CMT1A.
    Nolano M; Manganelli F; Provitera V; Pisciotta C; Stancanelli A; Caporaso G; Iodice R; Shy ME; Santoro L
    Neurology; 2015 Jan; 84(4):407-14. PubMed ID: 25540311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vivo reflectance confocal microscopy of Meissner's corpuscles in diabetic distal symmetric polyneuropathy.
    Creigh PD; McDermott MP; Sowden JE; Ferguson M; Herrmann DN
    J Neurol Sci; 2017 Jul; 378():213-219. PubMed ID: 28566167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and validity of the CMT neuropathy score as a measure of disability.
    Shy ME; Blake J; Krajewski K; Fuerst DR; Laura M; Hahn AF; Li J; Lewis RA; Reilly M
    Neurology; 2005 Apr; 64(7):1209-14. PubMed ID: 15824348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV neuropathy: an in vivo confocal microscopic study.
    Almodovar JL; Schifitto G; McDermott MP; Ferguson M; Herrmann DN
    J Neurovirol; 2012 Dec; 18(6):503-10. PubMed ID: 23070817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A.
    Eichinger K; Sowden JE; Burns J; McDermott MP; Krischer J; Thornton J; Pareyson D; Scherer SS; Shy ME; Reilly MM; Herrmann DN
    Front Neurol; 2022; 13():930435. PubMed ID: 35832173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor axon loss is associated with hand dysfunction in Charcot-Marie-Tooth disease 1a.
    Videler AJ; van Dijk JP; Beelen A; de Visser M; Nollet F; van Schaik IN
    Neurology; 2008 Oct; 71(16):1254-60. PubMed ID: 18852440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients.
    Sahenk Z; Nagaraja HN; McCracken BS; King WM; Freimer ML; Cedarbaum JM; Mendell JR
    Neurology; 2005 Sep; 65(5):681-9. PubMed ID: 16157899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients.
    Mannil M; Solari A; Leha A; Pelayo-Negro AL; Berciano J; Schlotter-Weigel B; Walter MC; Rautenstrauss B; Schnizer TJ; Schenone A; Seeman P; Kadian C; Schreiber O; Angarita NG; Fabrizi GM; Gemignani F; Padua L; Santoro L; Quattrone A; Vita G; Calabrese D; ; Young P; Laurà M; Haberlová J; Mazanec R; Paulus W; Beissbarth T; Shy ME; Reilly MM; Pareyson D; Sereda MW
    Neuromuscul Disord; 2014 Nov; 24(11):1003-17. PubMed ID: 25085517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Charcot-Marie-Tooth Neuropathy Score in children with type 1A disease.
    Haberlová J; Seeman P
    Pediatr Neurol; 2010 Dec; 43(6):407-10. PubMed ID: 21093731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal confocal microscopy detects small-fiber neuropathy in Charcot-Marie-Tooth disease type 1A patients.
    Tavakoli M; Marshall A; Banka S; Petropoulos IN; Fadavi H; Kingston H; Malik RA
    Muscle Nerve; 2012 Nov; 46(5):698-704. PubMed ID: 22996176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients.
    Wang W; Guedj M; Bertrand V; Foucquier J; Jouve E; Commenges D; Proust-Lima C; Murphy NP; Blin O; Magy L; Cohen D; Attarian S
    PLoS One; 2017; 12(1):e0169878. PubMed ID: 28095456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of Charcot Marie Tooth disease type 1A and diabetes in Taiwan: A clinicopathological study.
    Chao HC; Chou CT; Lee YC; Lin KP
    J Neurol Sci; 2015 Nov; 358(1-2):213-20. PubMed ID: 26349404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of comorbidities on the phenotype of patients affected by Charcot-Marie-Tooth neuropathy type 1A.
    Ursino G; Alberti MA; Grandis M; Reni L; Pareyson D; Bellone E; Gemelli C; Sabatelli M; Pisciotta C; Luigetti M; Santoro L; Massollo L; Schenone A
    Neuromuscul Disord; 2013 Nov; 23(11):902-6. PubMed ID: 23891256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripod pinch strength and thumb opposition are the major determinants of manual dexterity in Charcot-Marie-Tooth disease type 1A.
    Videler AJ; Beelen A; van Schaik IN; Verhamme C; van den Berg LH; de Visser M; Nollet F
    J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):828-33. PubMed ID: 20562406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor performance deterioration accelerates after 50 years of age in Charcot-Marie-Tooth type 1A patients.
    Tozza S; Bruzzese D; Pisciotta C; Iodice R; Esposito M; Dubbioso R; Ruggiero L; Topa A; Spina E; Santoro L; Manganelli F
    Eur J Neurol; 2018 Feb; 25(2):301-306. PubMed ID: 29053907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.